Log In
Print this Print this

uTASWako i30

  Manage Alerts
Collapse Summary General Information
Company Wako Pure Chemical Industries Ltd.
DescriptionMicrofluidic-based in vitro diagnostic
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsAssess the risk of developing hepatocellular carcinoma (HCC) in patients with chronic liver disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today